European Commission logo
español español
CORDIS - Resultados de investigaciones de la UE
CORDIS

Health Initiatives in Psoriasis and PsOriatic arthritis ConsoRTium European States

Descripción del proyecto

Avanzar en el diagnóstico y el tratamiento de la artritis psoriásica

La psoriasis es una enfermedad autoinmune de la piel asociada a la aparición de manchas rojas, secas y con picor, principalmente en codos, rodillas y cuero cabelludo. Algunos pacientes con psoriasis desarrollan un tipo de artritis inflamatoria conocida como artritis psoriásica (APs), que puede causar inflamación y rigidez en las articulaciones. Sin embargo, es difícil diagnosticar la APs y no hay forma de predecir qué pacientes desarrollarán la enfermedad o cómo responderán al tratamiento. HIPPOCRATES es un gran proyecto financiado con fondos europeos que reúne a expertos en investigación, diagnóstico clínico e industria para determinar los mecanismos de desarrollo y progresión de la APs. Los hallazgos del proyecto impulsarán futuros esfuerzos de descubrimiento de fármacos para el tratamiento de la enfermedad y la mejora de los resultados de los pacientes.

Objetivo

Psoriatic Arthritis (PsA) is a clinically heterogeneous disease associated with diminished quality of life. Early diagnosis is challenging and prediction of natural history or therapeutic response to treatment is suboptimal: these represent critical, contemporary unmet clinical needs. HIPPOCRATES is a multi-centre consortium, with 26 world-class partners that have clinical, scientific, data analytics, ethics, patient participation and pharmaceutical industry expertise. We will address these needs. Clinical phenotypic data from multiple established, and de novo PsA cohorts combined with a unique library of bio- samples, images, and data derived therefrom, will be curated and catalogued for optimal evaluation and use. HIPPOCRATES will analyse these multi-structured datasets that traverse the disease timeline, from cutaneous psoriasis, early PsA, first therapeutic and first biologic choice. Through machine learning and other AI techniques, we will: (1) Identify molecular signals associated with the development of PsA in patients with psoriasis, so presaging PsA prevention studies; (2) Create a diagnostic algorithm for early PsA diagnosis in patients with cutaneous psoriasis or early undifferentiated inflammatory arthritis; (3) Generate biomarker algorithms, including clinical, imaging and molecular polyomic moieties, to predict disease progression and identify endotypes permitting precision treatment with existing (methotrexate, and TNF or IL-17 inhibitor) treatments and novel therapeutic regimes; (4) Elucidate the molecular basis of PsA to facilitate future drug discovery; (5) Develop diagnostic digital tools for use in clinical settings. With highly aligned academic/clinical, SME and EFPIA partners, including involvement from existing IMI programmes and competitive international associations, HIPPOCRATES will oversee the development of a sustainable infrastructure to support PsA research and improve PsA patient outcomes.

Régimen de financiación

RIA - Research and Innovation action

Coordinador

UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN
Aportación neta de la UEn
€ 1 492 441,25
Dirección
BELFIELD
4 Dublin
Irlanda

Ver en el mapa

Región
Ireland Eastern and Midland Dublin
Tipo de actividad
Higher or Secondary Education Establishments
Enlaces
Coste total
€ 2 058 302,81

Participantes (28)